Arkolith/Insider Trading/SRPT/Form 4

Rodino-Klapac Louise

President, R&D and Tech OpsSarepta Therapeutics, Inc. (SRPT) · full profile →Form 4 · filed Mar 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Tax withholding(F)767$16.20$12K228K
Mar 2, 2026Tax withholding(F)4K$16.20$60K228K
Mar 1, 2026Option exercise(M)8K——232K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2026Option exercise(M)8K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-089425) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML